A detailed history of Veriti Management LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Veriti Management LLC holds 829 shares of BIO stock, worth $282,299. This represents 0.02% of its overall portfolio holdings.

Number of Shares
829
Holding current value
$282,299
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$263.97 - $344.64 $218,831 - $285,706
829 New
829 $277,000
Q1 2023

Apr 26, 2023

BUY
$418.69 - $503.0 $205,158 - $246,470
490 New
490 $234,000
Q1 2022

Apr 11, 2022

SELL
$524.57 - $735.42 $155,272 - $217,684
-296 Closed
0 $0
Q4 2021

Jan 19, 2022

BUY
$708.84 - $794.68 $12,759 - $14,304
18 Added 6.47%
296 $224,000
Q3 2021

Oct 08, 2021

BUY
$657.71 - $825.77 $182,843 - $229,564
278 New
278 $207,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.39B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.